LOKELMA

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: f03221ce81af941a
Drug Approval Canada Name: LOKELMA
Product Name: LOKELMA
Status: Marketed
Status Date: 2019-10-17
Original Market Date: 2019-10-17
Din: 02490714
Drug Class: Human
Dosage Form: Powder For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 40:18.18
Atc Original: V03AE10 SODIUM ZIRCONIUM CYCLOSILICATE
Atc Name: v 03 ae 10
Aig Number: 0161670001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

SODIUM ZIRCONIUM CYCLOSILICATE

5 G / SACHET

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f03221ce81af941a

Type

Standard